EIKN
Eikon Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
No implied move.
Next report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Eikon Therapeutics, Inc.
Expected move
No implied move.
Next report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Eikon Therapeutics, Inc.
5.36
+0.05 · +0.93%
Linked news
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $65.2M | 18.85% | +30.16% | |
| 2 | BlackRockBlackRockindex-like | $55.9M | 16.16% | +28.98% | |
| 3 | Foresite Capital Management IVForesite Capital Management IV | $25.4M | 7.34% | 0.00% | |
| 4 | MerckMerck | $21.7M | 6.29% | 0.00% | |
| 5 | T. Rowe Price Investment ManagementT. Rowe Price | $20.8M | 6.02% | +30.49% | |
| 6 | Foresite Capital Management VForesite Capital Management V | $17.2M | 4.98% | 0.00% | |
| 7 | Capital World InvestorsCapital World Investors | $15.3M | 4.44% | +2.82% | |
| 8 | T. Rowe Price AssociatesT. Rowe Price | $13.1M | 3.79% | +2.99% | |
| 9 | Vanguard Capital ManagementVanguardindex-like | $12.0M | 3.48% | −4.82% | |
| 10 | EcoR1 CapitalEcoR1 Capital | $9.6M | 2.77% | 0.00% | |
| 11 | AlliancebernsteinAlliancebernstein | $8.4M | 2.42% | −37.20% | |
| 12 | Geode Capital ManagementGeodeindex-like | $7.3M | 2.10% | +103.32% | |
| 13 | Baker Bros. AdvisorsBaker Bros. | $7.2M | 2.10% | 0.00% | |
| 14 | Soros Capital ManagementSoros | $6.3M | 1.83% | 0.00% | |
| 15 | StepStone GroupStepStone | $5.2M | 1.49% | 0.00% | |
| 16 | Canada Pension Plan Investment BoardCanada Pension Plan Investment Board | $4.9M | 1.43% | 0.00% | |
| 17 | State StreetState Streetindex-like | $4.6M | 1.34% | +781.93% | |
| 18 | Franklin ResourcesFranklin Resources | $4.6M | 1.32% | 0.00% | |
| 19 | General Catalyst Group ManagementGeneral Catalyst | $4.0M | 1.15% | 0.00% | |
| 20 | UBS GroupUBS | $3.4M | 1.00% | +165.50% | |
| 21 | Parkman Healthcare PartnersParkman Healthcare Partners | $3.3M | 0.97% | new | |
| 22 | Charles Schwab Investment ManagementCharles Schwabindex-like | $2.4M | 0.69% | +38.93% | |
| 23 | Schonfeld Strategic AdvisorsSchonfeld Strategic | $2.3M | 0.68% | new | |
| 24 | Northern TrustNorthern Trustindex-like | $2.3M | 0.66% | +286.39% | |
| 25 | Ensign Peak AdvisorsEnsign Peak | $2.2M | 0.64% | −14.75% |
No implied move.
No thesis.
77 managers report $345.7M of Eikon Therapeutics on form 13F for the quarter ended Jun 30 '26. 13 of them hold 80% of it; FMR is largest at 18.85%.